ESMO25 Breast Cancer Highlights Panel Discussion | Dana-Farber Cancer Institute

Описание: Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Nancy Lin, MD; Filipa Lynce, MD; and Ana C. Garrido-Castro, MD discuss important breast cancer research presented at ESMO 2025 including antibody-drug conjugates (ADCs) for ER+ early breast cancer, ADCs in advanced breast cancer, oral selective estrogen receptor degraders (SERDs) in advanced breast cancer, and CDK4/6 inhibitors (CDK4/6i) in early breast cancer.

For more information about Dana-Farber's Breast Oncology Center, visit https://www.dana-farber.org/cancer-ca...